Serologic responses to Bartonella and Afipia antigens in patients with cat scratch disease.

Objective: To assess the serologic response to Afipia and Bartonella, previously named Rochalimaea, in patients with cat scratch disease (CSD) and a healthy control group.

Design: Prospective, controlled trial.

Setting: Referral clinic and hospitalized patients in a university medical center.